Eosinophilic granulomatosis with polyangiitis in remission
Showing 1 - 25 of 3,243
Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Feb 9, 2022
Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome Trial (NS-229, Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
- NS-229
- Placebo
- (no location specified)
Sep 14, 2023
Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial in Paris (Rituximab, Placebo-rituximab, Cyclophosphamide)
Completed
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Apr 13, 2021
Eosinophilic Granulomatosis With Polyangiitis Trial (SHR-1703, SHR-1703 Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- SHR-1703
- SHR-1703 Placebo
- (no location specified)
Jul 30, 2023
Eosinophilic Granulomatosis With Polyangiitis Trial in Tulsa, Norfolk (Depemokimab, Mepolizumab, Placebo matching mepolizumab)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Depemokimab
- +3 more
-
Tulsa, Oklahoma
- +1 more
Jul 19, 2022
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
-
San Diego, California
- +9 more
May 16, 2022
Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia
Not yet recruiting
- Granulomatosis With Polyangiitis
- +2 more
-
Boston, Massachusetts
- +2 more
Dec 29, 2022
ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis Trial in Toronto (vitamin D)
Active, not recruiting
- ANCA-associated Vasculitis
- +3 more
- vitamin D
-
Toronto, CanadaMount Sinai Hospital, Vasculitis clinic
Feb 15, 2022
Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis Trial in Tampa (5 mg prednisone, 0 mg prednisone)
Active, not recruiting
- Granulomatosis With Polyangiitis
- +2 more
- 5 mg prednisone
- 0 mg prednisone
-
Tampa, FloridaUniversity of South Florida TAPIR Study Team
May 2, 2022
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Recruiting
- Cryoglobulinemic Vasculitis (CV)
- +9 more
-
Los Angeles, California
- +7 more
Jan 12, 2023
Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis, Churg Strauss Syndrome (Eosinophilic
Recruiting
- Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
- +6 more
-
San Francisco, California
- +37 more
Nov 4, 2022
Effectiveness of Eosinophilic Granulomatosis With Polyangiitis
Active, not recruiting
- Churg-Strauss Syndrome
-
Aichi, Japan
- +33 more
Sep 20, 2022
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis Trial in United States
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- +6 more
- Naltrexone Hydrochloride
- Placebo Comparator
-
Boston, Massachusetts
- +6 more
Jan 25, 2022
One-Time DNA Study for Vasculitis
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
- +5 more
-
Los Angeles, California
- +13 more
May 16, 2022
VCRC Tissue Repository
Recruiting
- Aortitis
- +10 more
-
Boston, Massachusetts
- +7 more
Jan 25, 2022
Granulomatosis With Polyangiitis Trial in Canada, United States (5 mg Prednisone, 0 mg Prednisone)
Recruiting
- Granulomatosis With Polyangiitis
- 5 mg Prednisone
- 0 mg Prednisone
-
Kansas City, Kansas
- +8 more
Jan 25, 2022
ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome Trial in United Kingdom (Hydroxychloroquine,
Recruiting
- ANCA Associated Vasculitis
- +3 more
- Hydroxychloroquine
- Placebo
-
Cardiff, United Kingdom
- +8 more
Mar 17, 2022
Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad Trial in Innsbruck (no intervention)
Recruiting
- Eosinophilic Asthma
- +4 more
- no intervention
-
Innsbruck, AustriaUniversity Clinic for Internal Medicine II
Sep 2, 2020
Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,
Not yet recruiting
- Granulomatosis With Polyangiitis
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- Rituximab
- +2 more
-
Paris, FranceHôpital de la Croix Saint Simon
Oct 10, 2022
Granulomatosis With Polyangiitis and Microscopic Polyangiitis
Completed
- Granulomatosis With Polyangiitis
- +2 more
-
Boston, Massachusetts
- +7 more
Jul 11, 2022
Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis Trial in Worldwide
Recruiting
- Granulomatosis With Polyangiitis (Wegener's)
- +3 more
- Abatacept
- placebo
-
Los Angeles, California
- +19 more
May 2, 2022
Neutrophils as Prognostic Factors in Granulomatosis With
Completed
- Granulomatosis With Polyangiitis
- Blood samples and clinical data
- Blood sample
-
Paris, FranceCochin Hospital
Apr 13, 2021
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared
Recruiting
- ANCA-associated Vasculitis
- +2 more
-
Calgary, Alberta, Canada
- +8 more
Jan 27, 2023
Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) Trial in Worldwide (IFX-1, Placebo-IFX-1, Glucocorticoid
Completed
- Granulomatosis With Polyangiitis (GPA)
- Microscopic Polyangiitis (MPA)
- IFX-1
- +3 more
-
Leuven, Belgium
- +75 more
Aug 3, 2022